Bradley Pharmaceuticals Overview
- Founded
- 1985
- Status
- Acquired/Merged
- Employees
- 300
- Latest Deal Type
- Buyout/LBO
- Financing Rounds
- 3
Bradley Pharmaceuticals General Information
Description
Operator of a specialty pharmaceutical company. The company markets to niche physician specialties in the U.S. and international markets. The company commercializes brands, develops new products through lifecycle management and in-licenses phase II and phase III drugs with long-term intellectual property protection. It specializes in pharmaceuticals for dermatology, podiatry, gastroenterology, women's health, respiratory and internal medicine products.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 383 Route 46 West
- Fairfield, NJ 07004
- United States
Bradley Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Bradley Pharmaceuticals‘s full profile, request access.
Request a free trialBradley Pharmaceuticals Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Daniel Glassman | President & Chief Executive Officer & Founder | ||
| Brent Lenczycki | Chief Financial Officer & Vice President |
Bradley Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial